Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Suzhou Zelgen Biopharmaceuticals Co., Ltd..The latest application filed is for "method for preparing chenodeoxycholic acid derivative".

Company Profile

4.14.10

Suzhou Zelgen Biopharmaceuticals Co., Ltd. - Jiangsu CN
Suzhou Zelgen Biopharmaceuticals Co., Ltd. - Kunshan Suzhou CN
Suzhou Zelgen Biopharmaceuticals Co., Ltd. - Kunshan Suzhou, Jiangsu N/A CN
Suzhou Zelgen Biopharmaceuticals Co., Ltd. - Kunshan Suzhou Jiangsu CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Preparing Chenodeoxycholic Acid Derivative App 20220162256 - LV; Binhua ; et al.	2022-05-26
Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds Grant 10,618,884 - Lv , et al.	2020-04-14
Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereof Grant 10,544,185 - Lv , et al. Ja	2020-01-28
Deuterated quinazolinone compound and pharmaceutical composition comprising same Grant 10,414,767 - Lv , et al. Sept	2019-09-17
Phenyl amino pyrimidine compound or polymorph of salt thereof Grant 10,377,725 - Lv , et al. A	2019-08-13
Phenyl Amino Pyrimidine Compound Or Polymorph Of Salt Thereof App 20180179169 - LV; Binhua ; et al.	2018-06-28
Deuterated Diaminopyrimidine Compounds And Pharmaceutical Compositions Comprising Such Compounds App 20180044323 - LV; Binhua ; et al.	2018-02-15
Polymorphs of deuterated omega-diphenylurea or salts thereof Grant 9,889,123 - Feng February 13, 2	2018-02-13
Deuterated Chenodeoxycholic Acid Derivative And Pharmaceutical Composition Comprising Compound Thereof App 20180030083 - LV; Binhua ; et al.	2018-02-01
Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compounds Grant 9,809,572 - Lv , et al. November 7, 2	2017-11-07
Deuterated Quinazolinone Compound And Pharmaceutical Composition Comprising Same App 20170305911 - LV; Binhua ; et al.	2017-10-26
Polymorphs Of Deuterated Omega-diphenylurea Or Salts Thereof App 20170128427 - FENG; Weidong	2017-05-11
Deuterated phenyl amino pyrimidine compound and pharmaceutical composition containing the same Grant 9,604,935 - LV , et al. March 28, 2	2017-03-28
Polymorphs of deuterated omega-diphenylurea or salts thereof Grant 9,573,900 - Feng February 21, 2	2017-02-21
Deuterated Diaminopyrimidine Compounds And Pharmaceutical Compositions Comprising Such Compounds App 20160185753 - LV; Binhua ; et al.	2016-06-30
Deuterated Phenyl Amino Pyrimidine Compound And Pharmaceutical Composition Containing Same App 20160060227 - LV; Binhua ; et al.	2016-03-03
Polymorphs Of Deuterated Omega-diphenylurea Or Salts Thereof App 20150266823 - Feng; Weidong	2015-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.